CorVel Q1 fiscal 2026 revenue rises 11% to $235 million; diluted EPS up 24% to $0.52
CorVel reported results for the quarter ended June 30, 2025, with revenue of $235 million, up from $212 million a year earlier, and diluted earnings per share of $0.52, up from $0.42. The company also said it completed, in July, the acquisition of assets and key talent from a privately held technology firm to strengthen its CERIS group health division; the filing does not state the purchase price.
Key points
- Revenue rose 11% to $235 million, versus $212 million in the June quarter of 2024.
- Diluted EPS rose 24% to $0.52 from $0.42, adjusted for the three-for-one stock split paid December 24, 2024.
- Gross profit rose 18% to $56.8 million, at a 24% gross margin, versus $48.2 million a year earlier.
- Cash was $202 million with no borrowings at quarter end; the company repurchased $9.6 million of common stock during the quarter.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.